IR@PKUHSC  > 北京大学第二临床医学院  > 麻醉科
学科主题临床医学
Comparison of Different Loading Dose of Celecoxib on Postoperative Anti-inflammation and Analgesia in Patients Undergoing Endoscopic Nasal Surgery-200 mg Is Equivalent to 400 mg
Zhao, Hong1; Feng, Yi1; Wang, Ying1; Yang, Baxian1; Xing, Zhimin2
关键词COX-2 Inhibitor Prostaglandin Preventive Analgesia
刊名PAIN MEDICINE
2011
DOI10.1111/j.1526-4637.2011.01196.x
12期:8页:1267-1275
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Medicine, General & Internal
资助者Pfizer for biochemical tests ; Pfizer for biochemical tests
研究领域[WOS]General & Internal Medicine
关键词[WOS]RANDOMIZED CONTROLLED-TRIAL ; PAIN MANAGEMENT ; ANTIINFLAMMATORY DRUGS ; TONSILLECTOMY ; RECOVERY ; RISK
英文摘要

Objective. To demonstrate the efficacy and non-inferiority of loading dose of celecoxib 200 mg compared with 400 mg in pain management after endoscopic nasal surgery.

Design. A prospective randomized controlled study.

Setting. A university hospital.

Patients. Consecutive 120 patients undergoing endoscopic nasal surgery under general anesthesia were randomly assigned to three groups of 40 patients each, celecoxib 400 mg, celecoxib 200 mg, or a control group with no celecoxib.

Interventions. Patients received different doses of celecoxib as described 1 hour before anesthesia. Two celecoxib groups received celecoxib 200 mg every 12 hours until the fifth day after surgery.

Outcome Measures. Noninferiority could be claimed if the lower limit of the confidence interval (CI) for pain score difference was greater than -0.6. At 0, 6, and 48 hours after surgery, prostaglandin E(2) (PGE(2)) and thromboxane A(2) (TXA(2)) to prostaglandin I(2) (PGI(2)) ratios were measured from incision drainage and in plasma.

Results. Estimated difference between two loading doses for pain scores over 5 days was 0.275 (95% CI -0.255 to 0.805, P > 0.05), indicating the noninferiority of celecoxib 200-400 mg. Local PGE(2) at 6 hours and 48 hours positively correlated with pain scores, with correlation coefficients 0.371 (P = 0.005) and 0.288 (P = 0.033). Systemic TXA(2) to PGI(2) ratios did not differ among groups.

Conclusions. An initial dose of celecoxib 200 mg was equivalent to celecoxib 400 mg with regard to the margin previously specified at -0.6 in reducing moderate postoperative pain in endoscopic nasal surgery both in analgesic efficacy and anti-inflammatory property. One hundred and twenty patients were included in this prospective randomized controlled study. Patients treated with celecoxib had lower pain scores than controls, pain scores correlating with local PGE(2) level. An initial dose of celecoxib 200 mg was equivalent to 400 mg in reducing moderate pain after endoscopic nasal surgery.

语种英语
所属项目编号IR8267
资助者Pfizer for biochemical tests ; Pfizer for biochemical tests
WOS记录号WOS:000293997700018
引用统计
被引频次:4[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63477
专题北京大学第二临床医学院_麻醉科
作者单位1.Peking Univ, Peoples Hosp, Dept Anesthesiol, Beijing, Peoples R China
2.Peking Univ, Peoples Hosp, Dept Otolaryngol, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Zhao, Hong,Feng, Yi,Wang, Ying,et al. Comparison of Different Loading Dose of Celecoxib on Postoperative Anti-inflammation and Analgesia in Patients Undergoing Endoscopic Nasal Surgery-200 mg Is Equivalent to 400 mg[J]. PAIN MEDICINE,2011,12(8):1267-1275.
APA Zhao, Hong,Feng, Yi,Wang, Ying,Yang, Baxian,&Xing, Zhimin.(2011).Comparison of Different Loading Dose of Celecoxib on Postoperative Anti-inflammation and Analgesia in Patients Undergoing Endoscopic Nasal Surgery-200 mg Is Equivalent to 400 mg.PAIN MEDICINE,12(8),1267-1275.
MLA Zhao, Hong,et al."Comparison of Different Loading Dose of Celecoxib on Postoperative Anti-inflammation and Analgesia in Patients Undergoing Endoscopic Nasal Surgery-200 mg Is Equivalent to 400 mg".PAIN MEDICINE 12.8(2011):1267-1275.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao, Hong]的文章
[Feng, Yi]的文章
[Wang, Ying]的文章
百度学术
百度学术中相似的文章
[Zhao, Hong]的文章
[Feng, Yi]的文章
[Wang, Ying]的文章
必应学术
必应学术中相似的文章
[Zhao, Hong]的文章
[Feng, Yi]的文章
[Wang, Ying]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。